Device Trial Radar · NCT04851847
A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTM
Last checked: Nov 20, 2026Latest source record: Mar 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
174
Actual
Start
Jun 10, 2021
Primary completion
Jul 20, 2022
Study completion Aug 1, 2022
Sponsor
- Lead sponsor
- Collagen MatrixNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 21, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, single blind, parallel-arm, multi-center, non-inferior clinical trial. 174 patients are recruited in total, and they are treated by Guided Tissue Regeneration (GTR). The patients are split in to two groups evenly: 87 in the experimental group and 87 in the control group.
Conditions
- Periodontal Diseases
- Intrabony Defects
- Guided Tissue Regeneration
Interventions
Guided Tissue Regeneration (GTR)Device
Use of resorbable collagen membrane to treat periodontal intrabony defects.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change of CAL at 12 weeks after surgeryTime frame: 12 weeks
- The change of CAL at 24 weeks after surgeryTime frame: 24 weeks
- The change of PD at 12 weeks after surgeryTime frame: 12 weeks
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.